nodes	percent_of_prediction	percent_of_DWPC	metapath
Testosterone—Exemestane—Prednisone—systemic scleroderma	0.0456	0.102	CrCrCtD
Testosterone—Testolactone—Mometasone—systemic scleroderma	0.0437	0.0974	CrCrCtD
Testosterone—ABCG2—Leflunomide—systemic scleroderma	0.0431	0.117	CbGbCtD
Testosterone—Fluoxymesterone—Mometasone—systemic scleroderma	0.0402	0.0895	CrCrCtD
Testosterone—Fludrocortisone—Mometasone—systemic scleroderma	0.0392	0.0872	CrCrCtD
Testosterone—CYP2C8—Mometasone—systemic scleroderma	0.0356	0.0964	CbGbCtD
Testosterone—Potassium Canrenoate—Prednisone—systemic scleroderma	0.0345	0.0768	CrCrCtD
Testosterone—Prednisolone—Mometasone—systemic scleroderma	0.0333	0.0741	CrCrCtD
Testosterone—Hydrocortisone—Mometasone—systemic scleroderma	0.0319	0.0711	CrCrCtD
Testosterone—Danazol—Prednisone—systemic scleroderma	0.0291	0.0649	CrCrCtD
Testosterone—SLCO1A2—Prednisone—systemic scleroderma	0.0284	0.0769	CbGbCtD
Testosterone—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0266	0.0721	CbGbCtD
Testosterone—Hydrocortamate—Prednisone—systemic scleroderma	0.0254	0.0564	CrCrCtD
Testosterone—Cortisone acetate—Prednisone—systemic scleroderma	0.0246	0.0547	CrCrCtD
Testosterone—Testolactone—Prednisone—systemic scleroderma	0.0238	0.0531	CrCrCtD
Testosterone—ALB—Captopril—systemic scleroderma	0.0233	0.0631	CbGbCtD
Testosterone—Fludrocortisone—Prednisone—systemic scleroderma	0.0213	0.0475	CrCrCtD
Testosterone—Methyltestosterone—Prednisone—systemic scleroderma	0.0208	0.0463	CrCrCtD
Testosterone—SLC22A7—Methotrexate—systemic scleroderma	0.0203	0.055	CbGbCtD
Testosterone—ALB—Mycophenolate mofetil—systemic scleroderma	0.0183	0.0497	CbGbCtD
Testosterone—Prednisolone—Prednisone—systemic scleroderma	0.0181	0.0404	CrCrCtD
Testosterone—Hydrocortisone—Prednisone—systemic scleroderma	0.0174	0.0387	CrCrCtD
Testosterone—ABCB1—Lisinopril—systemic scleroderma	0.0163	0.0441	CbGbCtD
Testosterone—CYP2C9—Leflunomide—systemic scleroderma	0.016	0.0433	CbGbCtD
Testosterone—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0147	0.0399	CbGbCtD
Testosterone—ALB—Prednisone—systemic scleroderma	0.0147	0.0397	CbGbCtD
Testosterone—SLCO1A2—Methotrexate—systemic scleroderma	0.0142	0.0386	CbGbCtD
Testosterone—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0142	0.0384	CbGbCtD
Testosterone—SLC22A8—Methotrexate—systemic scleroderma	0.0124	0.0336	CbGbCtD
Testosterone—ABCB1—Captopril—systemic scleroderma	0.0122	0.033	CbGbCtD
Testosterone—ABCG2—Methotrexate—systemic scleroderma	0.0107	0.0289	CbGbCtD
Testosterone—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0096	0.026	CbGbCtD
Testosterone—CYP2C19—Prednisone—systemic scleroderma	0.00951	0.0257	CbGbCtD
Testosterone—ABCB1—Prednisone—systemic scleroderma	0.00767	0.0208	CbGbCtD
Testosterone—ALB—Methotrexate—systemic scleroderma	0.00736	0.0199	CbGbCtD
Testosterone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00575	0.0156	CbGbCtD
Testosterone—CYP3A4—Prednisone—systemic scleroderma	0.0046	0.0124	CbGbCtD
Testosterone—CYP2C9—cardial valve—systemic scleroderma	0.00439	0.239	CbGeAlD
Testosterone—ABCB1—Methotrexate—systemic scleroderma	0.00385	0.0104	CbGbCtD
Testosterone—CYP2A13—lung—systemic scleroderma	0.00135	0.0734	CbGeAlD
Testosterone—CYP11A1—connective tissue—systemic scleroderma	0.000637	0.0347	CbGeAlD
Testosterone—Danazol—CCL2—systemic scleroderma	0.000624	1	CrCbGaD
Testosterone—SLC10A1—digestive system—systemic scleroderma	0.000568	0.031	CbGeAlD
Testosterone—SHBG—connective tissue—systemic scleroderma	0.000511	0.0278	CbGeAlD
Testosterone—SLC22A7—digestive system—systemic scleroderma	0.000506	0.0276	CbGeAlD
Testosterone—SLC22A3—connective tissue—systemic scleroderma	0.000421	0.023	CbGeAlD
Testosterone—CYP19A1—connective tissue—systemic scleroderma	0.000414	0.0226	CbGeAlD
Testosterone—CYP1B1—connective tissue—systemic scleroderma	0.000387	0.0211	CbGeAlD
Testosterone—SLC22A3—smooth muscle tissue—systemic scleroderma	0.000385	0.021	CbGeAlD
Testosterone—AR—connective tissue—systemic scleroderma	0.000366	0.02	CbGeAlD
Testosterone—CYP1B1—smooth muscle tissue—systemic scleroderma	0.000354	0.0193	CbGeAlD
Testosterone—CYP1B1—skin of body—systemic scleroderma	0.000349	0.019	CbGeAlD
Testosterone—AR—smooth muscle tissue—systemic scleroderma	0.000335	0.0183	CbGeAlD
Testosterone—SLC22A4—digestive system—systemic scleroderma	0.000334	0.0182	CbGeAlD
Testosterone—MAOA—connective tissue—systemic scleroderma	0.000332	0.0181	CbGeAlD
Testosterone—AR—skin of body—systemic scleroderma	0.000331	0.018	CbGeAlD
Testosterone—SLC22A4—tendon—systemic scleroderma	0.000318	0.0173	CbGeAlD
Testosterone—SLCO1A2—digestive system—systemic scleroderma	0.000306	0.0167	CbGeAlD
Testosterone—CYP1B1—digestive system—systemic scleroderma	0.00028	0.0152	CbGeAlD
Testosterone—SLC22A4—lung—systemic scleroderma	0.000279	0.0152	CbGeAlD
Testosterone—ABCB1—blood vessel—systemic scleroderma	0.000277	0.0151	CbGeAlD
Testosterone—CYP1B1—tendon—systemic scleroderma	0.000266	0.0145	CbGeAlD
Testosterone—AR—digestive system—systemic scleroderma	0.000265	0.0144	CbGeAlD
Testosterone—SLCO1A2—lung—systemic scleroderma	0.000256	0.0139	CbGeAlD
Testosterone—SLC22A3—lung—systemic scleroderma	0.000254	0.0138	CbGeAlD
Testosterone—AR—tendon—systemic scleroderma	0.000252	0.0137	CbGeAlD
Testosterone—CYP1A1—skin of body—systemic scleroderma	0.000247	0.0135	CbGeAlD
Testosterone—CYP2C19—digestive system—systemic scleroderma	0.000245	0.0134	CbGeAlD
Testosterone—MAOA—digestive system—systemic scleroderma	0.00024	0.0131	CbGeAlD
Testosterone—CYP2B6—skin of body—systemic scleroderma	0.00024	0.0131	CbGeAlD
Testosterone—CYP1B1—lung—systemic scleroderma	0.000233	0.0127	CbGeAlD
Testosterone—MAOA—tendon—systemic scleroderma	0.000228	0.0125	CbGeAlD
Testosterone—AR—lung—systemic scleroderma	0.000221	0.0121	CbGeAlD
Testosterone—MAOA—lung—systemic scleroderma	0.000201	0.0109	CbGeAlD
Testosterone—CYP1A1—digestive system—systemic scleroderma	0.000198	0.0108	CbGeAlD
Testosterone—CYP3A5—digestive system—systemic scleroderma	0.000193	0.0105	CbGeAlD
Testosterone—CYP2B6—digestive system—systemic scleroderma	0.000192	0.0105	CbGeAlD
Testosterone—CYP2C9—digestive system—systemic scleroderma	0.00019	0.0104	CbGeAlD
Testosterone—ABCG2—lung—systemic scleroderma	0.000174	0.00948	CbGeAlD
Testosterone—CYP1A1—lung—systemic scleroderma	0.000165	0.009	CbGeAlD
Testosterone—CYP3A5—lung—systemic scleroderma	0.000161	0.0088	CbGeAlD
Testosterone—CYP2B6—lung—systemic scleroderma	0.00016	0.00874	CbGeAlD
Testosterone—CYP3A4—digestive system—systemic scleroderma	0.000145	0.0079	CbGeAlD
Testosterone—ABCB1—digestive system—systemic scleroderma	0.000103	0.00559	CbGeAlD
Testosterone—ABCB1—lung—systemic scleroderma	8.57e-05	0.00467	CbGeAlD
Testosterone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	7.87e-05	0.000485	CcSEcCtD
Testosterone—Pain—Leflunomide—systemic scleroderma	7.86e-05	0.000484	CcSEcCtD
Testosterone—Infection—Lisinopril—systemic scleroderma	7.85e-05	0.000483	CcSEcCtD
Testosterone—Anaemia—Mycophenolate mofetil—systemic scleroderma	7.84e-05	0.000483	CcSEcCtD
Testosterone—Dyspnoea—Mycophenolic acid—systemic scleroderma	7.82e-05	0.000481	CcSEcCtD
Testosterone—Agitation—Mycophenolate mofetil—systemic scleroderma	7.79e-05	0.00048	CcSEcCtD
Testosterone—Shock—Lisinopril—systemic scleroderma	7.77e-05	0.000479	CcSEcCtD
Testosterone—Angioedema—Mycophenolate mofetil—systemic scleroderma	7.75e-05	0.000477	CcSEcCtD
Testosterone—Thrombocytopenia—Lisinopril—systemic scleroderma	7.74e-05	0.000476	CcSEcCtD
Testosterone—Tachycardia—Lisinopril—systemic scleroderma	7.71e-05	0.000475	CcSEcCtD
Testosterone—Abdominal pain—Azathioprine—systemic scleroderma	7.7e-05	0.000474	CcSEcCtD
Testosterone—Skin disorder—Lisinopril—systemic scleroderma	7.67e-05	0.000472	CcSEcCtD
Testosterone—Malaise—Mycophenolate mofetil—systemic scleroderma	7.65e-05	0.000471	CcSEcCtD
Testosterone—Hyperhidrosis—Lisinopril—systemic scleroderma	7.64e-05	0.00047	CcSEcCtD
Testosterone—Diarrhoea—Captopril—systemic scleroderma	7.63e-05	0.00047	CcSEcCtD
Testosterone—Vertigo—Mycophenolate mofetil—systemic scleroderma	7.62e-05	0.000469	CcSEcCtD
Testosterone—Irritability—Methotrexate—systemic scleroderma	7.62e-05	0.000469	CcSEcCtD
Testosterone—Syncope—Mycophenolate mofetil—systemic scleroderma	7.61e-05	0.000468	CcSEcCtD
Testosterone—Erectile dysfunction—Prednisone—systemic scleroderma	7.6e-05	0.000468	CcSEcCtD
Testosterone—Feeling abnormal—Leflunomide—systemic scleroderma	7.58e-05	0.000466	CcSEcCtD
Testosterone—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	7.57e-05	0.000466	CcSEcCtD
Testosterone—Fatigue—Mycophenolic acid—systemic scleroderma	7.56e-05	0.000466	CcSEcCtD
Testosterone—Mood swings—Methotrexate—systemic scleroderma	7.56e-05	0.000465	CcSEcCtD
Testosterone—Nausea—Mometasone—systemic scleroderma	7.54e-05	0.000465	CcSEcCtD
Testosterone—Gastrointestinal pain—Leflunomide—systemic scleroderma	7.52e-05	0.000463	CcSEcCtD
Testosterone—Weight increased—Prednisone—systemic scleroderma	7.51e-05	0.000462	CcSEcCtD
Testosterone—Pain—Mycophenolic acid—systemic scleroderma	7.5e-05	0.000462	CcSEcCtD
Testosterone—Palpitations—Mycophenolate mofetil—systemic scleroderma	7.5e-05	0.000461	CcSEcCtD
Testosterone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	7.45e-05	0.000459	CcSEcCtD
Testosterone—Cough—Mycophenolate mofetil—systemic scleroderma	7.4e-05	0.000456	CcSEcCtD
Testosterone—Dizziness—Captopril—systemic scleroderma	7.38e-05	0.000454	CcSEcCtD
Testosterone—Liver function test abnormal—Methotrexate—systemic scleroderma	7.37e-05	0.000454	CcSEcCtD
Testosterone—Depression—Prednisone—systemic scleroderma	7.34e-05	0.000452	CcSEcCtD
Testosterone—Hypertension—Mycophenolate mofetil—systemic scleroderma	7.32e-05	0.000451	CcSEcCtD
Testosterone—Urticaria—Leflunomide—systemic scleroderma	7.3e-05	0.00045	CcSEcCtD
Testosterone—Abdominal pain—Leflunomide—systemic scleroderma	7.27e-05	0.000448	CcSEcCtD
Testosterone—Acute coronary syndrome—Prednisone—systemic scleroderma	7.25e-05	0.000447	CcSEcCtD
Testosterone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	7.23e-05	0.000445	CcSEcCtD
Testosterone—Chest pain—Mycophenolate mofetil—systemic scleroderma	7.22e-05	0.000445	CcSEcCtD
Testosterone—Myalgia—Mycophenolate mofetil—systemic scleroderma	7.22e-05	0.000445	CcSEcCtD
Testosterone—Arthralgia—Mycophenolate mofetil—systemic scleroderma	7.22e-05	0.000445	CcSEcCtD
Testosterone—Myocardial infarction—Prednisone—systemic scleroderma	7.21e-05	0.000444	CcSEcCtD
Testosterone—Breast disorder—Methotrexate—systemic scleroderma	7.21e-05	0.000444	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	7.2e-05	0.000443	CcSEcCtD
Testosterone—Anxiety—Mycophenolate mofetil—systemic scleroderma	7.2e-05	0.000443	CcSEcCtD
Testosterone—Hypersensitivity—Azathioprine—systemic scleroderma	7.17e-05	0.000442	CcSEcCtD
Testosterone—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	7.17e-05	0.000442	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	7.17e-05	0.000442	CcSEcCtD
Testosterone—Insomnia—Lisinopril—systemic scleroderma	7.15e-05	0.00044	CcSEcCtD
Testosterone—Discomfort—Mycophenolate mofetil—systemic scleroderma	7.13e-05	0.000439	CcSEcCtD
Testosterone—Paraesthesia—Lisinopril—systemic scleroderma	7.09e-05	0.000437	CcSEcCtD
Testosterone—Vomiting—Captopril—systemic scleroderma	7.09e-05	0.000437	CcSEcCtD
Testosterone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	7.06e-05	0.000435	CcSEcCtD
Testosterone—Dyspnoea—Lisinopril—systemic scleroderma	7.04e-05	0.000434	CcSEcCtD
Testosterone—Rash—Captopril—systemic scleroderma	7.03e-05	0.000433	CcSEcCtD
Testosterone—Dermatitis—Captopril—systemic scleroderma	7.03e-05	0.000433	CcSEcCtD
Testosterone—Headache—Captopril—systemic scleroderma	6.99e-05	0.00043	CcSEcCtD
Testosterone—Confusional state—Mycophenolate mofetil—systemic scleroderma	6.98e-05	0.00043	CcSEcCtD
Testosterone—Abdominal pain—Mycophenolic acid—systemic scleroderma	6.93e-05	0.000427	CcSEcCtD
Testosterone—Oedema—Mycophenolate mofetil—systemic scleroderma	6.92e-05	0.000426	CcSEcCtD
Testosterone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	6.92e-05	0.000426	CcSEcCtD
Testosterone—Asthma—Methotrexate—systemic scleroderma	6.9e-05	0.000425	CcSEcCtD
Testosterone—Infection—Mycophenolate mofetil—systemic scleroderma	6.88e-05	0.000423	CcSEcCtD
Testosterone—Gastrointestinal disorder—Lisinopril—systemic scleroderma	6.82e-05	0.00042	CcSEcCtD
Testosterone—Fatigue—Lisinopril—systemic scleroderma	6.81e-05	0.000419	CcSEcCtD
Testosterone—Shock—Mycophenolate mofetil—systemic scleroderma	6.81e-05	0.000419	CcSEcCtD
Testosterone—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	6.79e-05	0.000418	CcSEcCtD
Testosterone—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	6.78e-05	0.000417	CcSEcCtD
Testosterone—Hypersensitivity—Leflunomide—systemic scleroderma	6.77e-05	0.000417	CcSEcCtD
Testosterone—Pain—Lisinopril—systemic scleroderma	6.76e-05	0.000416	CcSEcCtD
Testosterone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	6.76e-05	0.000416	CcSEcCtD
Testosterone—Skin disorder—Mycophenolate mofetil—systemic scleroderma	6.72e-05	0.000414	CcSEcCtD
Testosterone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	6.69e-05	0.000412	CcSEcCtD
Testosterone—Diarrhoea—Azathioprine—systemic scleroderma	6.66e-05	0.00041	CcSEcCtD
Testosterone—Haemoglobin—Prednisone—systemic scleroderma	6.64e-05	0.000409	CcSEcCtD
Testosterone—Nausea—Captopril—systemic scleroderma	6.63e-05	0.000408	CcSEcCtD
Testosterone—Haemorrhage—Prednisone—systemic scleroderma	6.6e-05	0.000407	CcSEcCtD
Testosterone—Asthenia—Leflunomide—systemic scleroderma	6.6e-05	0.000406	CcSEcCtD
Testosterone—Feeling abnormal—Lisinopril—systemic scleroderma	6.51e-05	0.000401	CcSEcCtD
Testosterone—Pruritus—Leflunomide—systemic scleroderma	6.51e-05	0.000401	CcSEcCtD
Testosterone—Connective tissue disorder—Prednisone—systemic scleroderma	6.49e-05	0.0004	CcSEcCtD
Testosterone—Gastrointestinal pain—Lisinopril—systemic scleroderma	6.46e-05	0.000398	CcSEcCtD
Testosterone—Dysuria—Methotrexate—systemic scleroderma	6.45e-05	0.000397	CcSEcCtD
Testosterone—Dizziness—Azathioprine—systemic scleroderma	6.44e-05	0.000396	CcSEcCtD
Testosterone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	6.41e-05	0.000395	CcSEcCtD
Testosterone—Erectile dysfunction—Methotrexate—systemic scleroderma	6.35e-05	0.000391	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	6.31e-05	0.000388	CcSEcCtD
Testosterone—Asthenia—Mycophenolic acid—systemic scleroderma	6.29e-05	0.000387	CcSEcCtD
Testosterone—Diarrhoea—Leflunomide—systemic scleroderma	6.29e-05	0.000387	CcSEcCtD
Testosterone—Urticaria—Lisinopril—systemic scleroderma	6.28e-05	0.000386	CcSEcCtD
Testosterone—Insomnia—Mycophenolate mofetil—systemic scleroderma	6.26e-05	0.000385	CcSEcCtD
Testosterone—Abdominal pain—Lisinopril—systemic scleroderma	6.25e-05	0.000385	CcSEcCtD
Testosterone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	6.22e-05	0.000383	CcSEcCtD
Testosterone—Pruritus—Mycophenolic acid—systemic scleroderma	6.21e-05	0.000382	CcSEcCtD
Testosterone—Vomiting—Azathioprine—systemic scleroderma	6.19e-05	0.000381	CcSEcCtD
Testosterone—Pneumonia—Methotrexate—systemic scleroderma	6.18e-05	0.000381	CcSEcCtD
Testosterone—Eye disorder—Prednisone—systemic scleroderma	6.17e-05	0.00038	CcSEcCtD
Testosterone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	6.17e-05	0.00038	CcSEcCtD
Testosterone—Infestation—Methotrexate—systemic scleroderma	6.15e-05	0.000379	CcSEcCtD
Testosterone—Infestation NOS—Methotrexate—systemic scleroderma	6.15e-05	0.000379	CcSEcCtD
Testosterone—Rash—Azathioprine—systemic scleroderma	6.14e-05	0.000378	CcSEcCtD
Testosterone—Dermatitis—Azathioprine—systemic scleroderma	6.13e-05	0.000378	CcSEcCtD
Testosterone—Depression—Methotrexate—systemic scleroderma	6.13e-05	0.000377	CcSEcCtD
Testosterone—Headache—Azathioprine—systemic scleroderma	6.1e-05	0.000376	CcSEcCtD
Testosterone—Dizziness—Leflunomide—systemic scleroderma	6.08e-05	0.000374	CcSEcCtD
Testosterone—Renal failure—Methotrexate—systemic scleroderma	6.04e-05	0.000372	CcSEcCtD
Testosterone—Diarrhoea—Mycophenolic acid—systemic scleroderma	6e-05	0.00037	CcSEcCtD
Testosterone—Stomatitis—Methotrexate—systemic scleroderma	5.99e-05	0.000369	CcSEcCtD
Testosterone—Angiopathy—Prednisone—systemic scleroderma	5.99e-05	0.000369	CcSEcCtD
Testosterone—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	5.98e-05	0.000368	CcSEcCtD
Testosterone—Immune system disorder—Prednisone—systemic scleroderma	5.97e-05	0.000367	CcSEcCtD
Testosterone—Pain—Mycophenolate mofetil—systemic scleroderma	5.92e-05	0.000364	CcSEcCtD
Testosterone—Sweating—Methotrexate—systemic scleroderma	5.89e-05	0.000363	CcSEcCtD
Testosterone—Haematuria—Methotrexate—systemic scleroderma	5.86e-05	0.000361	CcSEcCtD
Testosterone—Vomiting—Leflunomide—systemic scleroderma	5.85e-05	0.00036	CcSEcCtD
Testosterone—Alopecia—Prednisone—systemic scleroderma	5.84e-05	0.000359	CcSEcCtD
Testosterone—Hypersensitivity—Lisinopril—systemic scleroderma	5.82e-05	0.000358	CcSEcCtD
Testosterone—Hepatobiliary disease—Methotrexate—systemic scleroderma	5.82e-05	0.000358	CcSEcCtD
Testosterone—Dizziness—Mycophenolic acid—systemic scleroderma	5.8e-05	0.000357	CcSEcCtD
Testosterone—Rash—Leflunomide—systemic scleroderma	5.8e-05	0.000357	CcSEcCtD
Testosterone—Dermatitis—Leflunomide—systemic scleroderma	5.79e-05	0.000357	CcSEcCtD
Testosterone—Mental disorder—Prednisone—systemic scleroderma	5.79e-05	0.000356	CcSEcCtD
Testosterone—Nausea—Azathioprine—systemic scleroderma	5.78e-05	0.000356	CcSEcCtD
Testosterone—Headache—Leflunomide—systemic scleroderma	5.76e-05	0.000355	CcSEcCtD
Testosterone—Erythema—Prednisone—systemic scleroderma	5.75e-05	0.000354	CcSEcCtD
Testosterone—Malnutrition—Prednisone—systemic scleroderma	5.75e-05	0.000354	CcSEcCtD
Testosterone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	5.7e-05	0.000351	CcSEcCtD
Testosterone—Asthenia—Lisinopril—systemic scleroderma	5.67e-05	0.000349	CcSEcCtD
Testosterone—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	5.66e-05	0.000349	CcSEcCtD
Testosterone—Pruritus—Lisinopril—systemic scleroderma	5.59e-05	0.000344	CcSEcCtD
Testosterone—Vomiting—Mycophenolic acid—systemic scleroderma	5.58e-05	0.000343	CcSEcCtD
Testosterone—Haemoglobin—Methotrexate—systemic scleroderma	5.55e-05	0.000342	CcSEcCtD
Testosterone—Rash—Mycophenolic acid—systemic scleroderma	5.53e-05	0.000341	CcSEcCtD
Testosterone—Dermatitis—Mycophenolic acid—systemic scleroderma	5.53e-05	0.00034	CcSEcCtD
Testosterone—Haemorrhage—Methotrexate—systemic scleroderma	5.52e-05	0.00034	CcSEcCtD
Testosterone—Urticaria—Mycophenolate mofetil—systemic scleroderma	5.5e-05	0.000339	CcSEcCtD
Testosterone—Headache—Mycophenolic acid—systemic scleroderma	5.5e-05	0.000338	CcSEcCtD
Testosterone—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	5.47e-05	0.000337	CcSEcCtD
Testosterone—Nausea—Leflunomide—systemic scleroderma	5.46e-05	0.000336	CcSEcCtD
Testosterone—Urinary tract disorder—Methotrexate—systemic scleroderma	5.45e-05	0.000336	CcSEcCtD
Testosterone—Urethral disorder—Methotrexate—systemic scleroderma	5.41e-05	0.000333	CcSEcCtD
Testosterone—Diarrhoea—Lisinopril—systemic scleroderma	5.41e-05	0.000333	CcSEcCtD
Testosterone—Ill-defined disorder—Prednisone—systemic scleroderma	5.33e-05	0.000328	CcSEcCtD
Testosterone—Anaemia—Prednisone—systemic scleroderma	5.31e-05	0.000327	CcSEcCtD
Testosterone—Agitation—Prednisone—systemic scleroderma	5.28e-05	0.000325	CcSEcCtD
Testosterone—Angioedema—Prednisone—systemic scleroderma	5.25e-05	0.000323	CcSEcCtD
Testosterone—Dizziness—Lisinopril—systemic scleroderma	5.22e-05	0.000322	CcSEcCtD
Testosterone—Nausea—Mycophenolic acid—systemic scleroderma	5.21e-05	0.000321	CcSEcCtD
Testosterone—Malaise—Prednisone—systemic scleroderma	5.18e-05	0.000319	CcSEcCtD
Testosterone—Vertigo—Prednisone—systemic scleroderma	5.17e-05	0.000318	CcSEcCtD
Testosterone—Eye disorder—Methotrexate—systemic scleroderma	5.16e-05	0.000318	CcSEcCtD
Testosterone—Syncope—Prednisone—systemic scleroderma	5.16e-05	0.000317	CcSEcCtD
Testosterone—Tinnitus—Methotrexate—systemic scleroderma	5.15e-05	0.000317	CcSEcCtD
Testosterone—Cardiac disorder—Methotrexate—systemic scleroderma	5.12e-05	0.000315	CcSEcCtD
Testosterone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	5.1e-05	0.000314	CcSEcCtD
Testosterone—Loss of consciousness—Prednisone—systemic scleroderma	5.05e-05	0.000311	CcSEcCtD
Testosterone—Vomiting—Lisinopril—systemic scleroderma	5.02e-05	0.000309	CcSEcCtD
Testosterone—Angiopathy—Methotrexate—systemic scleroderma	5.01e-05	0.000308	CcSEcCtD
Testosterone—Immune system disorder—Methotrexate—systemic scleroderma	4.99e-05	0.000307	CcSEcCtD
Testosterone—Rash—Lisinopril—systemic scleroderma	4.98e-05	0.000307	CcSEcCtD
Testosterone—Dermatitis—Lisinopril—systemic scleroderma	4.98e-05	0.000306	CcSEcCtD
Testosterone—Mediastinal disorder—Methotrexate—systemic scleroderma	4.97e-05	0.000306	CcSEcCtD
Testosterone—Asthenia—Mycophenolate mofetil—systemic scleroderma	4.97e-05	0.000306	CcSEcCtD
Testosterone—Hypertension—Prednisone—systemic scleroderma	4.96e-05	0.000306	CcSEcCtD
Testosterone—Chills—Methotrexate—systemic scleroderma	4.95e-05	0.000305	CcSEcCtD
Testosterone—Headache—Lisinopril—systemic scleroderma	4.95e-05	0.000305	CcSEcCtD
Testosterone—Pruritus—Mycophenolate mofetil—systemic scleroderma	4.9e-05	0.000302	CcSEcCtD
Testosterone—Arthralgia—Prednisone—systemic scleroderma	4.89e-05	0.000301	CcSEcCtD
Testosterone—Myalgia—Prednisone—systemic scleroderma	4.89e-05	0.000301	CcSEcCtD
Testosterone—Anxiety—Prednisone—systemic scleroderma	4.88e-05	0.0003	CcSEcCtD
Testosterone—Alopecia—Methotrexate—systemic scleroderma	4.88e-05	0.0003	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	4.86e-05	0.000299	CcSEcCtD
Testosterone—Discomfort—Prednisone—systemic scleroderma	4.84e-05	0.000298	CcSEcCtD
Testosterone—Mental disorder—Methotrexate—systemic scleroderma	4.84e-05	0.000298	CcSEcCtD
Testosterone—Erythema—Methotrexate—systemic scleroderma	4.8e-05	0.000296	CcSEcCtD
Testosterone—Malnutrition—Methotrexate—systemic scleroderma	4.8e-05	0.000296	CcSEcCtD
Testosterone—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	4.74e-05	0.000292	CcSEcCtD
Testosterone—Dysgeusia—Methotrexate—systemic scleroderma	4.71e-05	0.00029	CcSEcCtD
Testosterone—Nausea—Lisinopril—systemic scleroderma	4.69e-05	0.000289	CcSEcCtD
Testosterone—Oedema—Prednisone—systemic scleroderma	4.69e-05	0.000289	CcSEcCtD
Testosterone—Anaphylactic shock—Prednisone—systemic scleroderma	4.69e-05	0.000289	CcSEcCtD
Testosterone—Infection—Prednisone—systemic scleroderma	4.66e-05	0.000287	CcSEcCtD
Testosterone—Back pain—Methotrexate—systemic scleroderma	4.65e-05	0.000286	CcSEcCtD
Testosterone—Shock—Prednisone—systemic scleroderma	4.62e-05	0.000284	CcSEcCtD
Testosterone—Nervous system disorder—Prednisone—systemic scleroderma	4.6e-05	0.000283	CcSEcCtD
Testosterone—Tachycardia—Prednisone—systemic scleroderma	4.58e-05	0.000282	CcSEcCtD
Testosterone—Dizziness—Mycophenolate mofetil—systemic scleroderma	4.58e-05	0.000282	CcSEcCtD
Testosterone—Skin disorder—Prednisone—systemic scleroderma	4.56e-05	0.000281	CcSEcCtD
Testosterone—Hyperhidrosis—Prednisone—systemic scleroderma	4.54e-05	0.000279	CcSEcCtD
Testosterone—Ill-defined disorder—Methotrexate—systemic scleroderma	4.46e-05	0.000274	CcSEcCtD
Testosterone—Anaemia—Methotrexate—systemic scleroderma	4.44e-05	0.000273	CcSEcCtD
Testosterone—Vomiting—Mycophenolate mofetil—systemic scleroderma	4.4e-05	0.000271	CcSEcCtD
Testosterone—Rash—Mycophenolate mofetil—systemic scleroderma	4.36e-05	0.000269	CcSEcCtD
Testosterone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	4.36e-05	0.000268	CcSEcCtD
Testosterone—Headache—Mycophenolate mofetil—systemic scleroderma	4.34e-05	0.000267	CcSEcCtD
Testosterone—Malaise—Methotrexate—systemic scleroderma	4.33e-05	0.000267	CcSEcCtD
Testosterone—Vertigo—Methotrexate—systemic scleroderma	4.32e-05	0.000266	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	4.28e-05	0.000263	CcSEcCtD
Testosterone—Insomnia—Prednisone—systemic scleroderma	4.24e-05	0.000261	CcSEcCtD
Testosterone—Paraesthesia—Prednisone—systemic scleroderma	4.21e-05	0.000259	CcSEcCtD
Testosterone—Cough—Methotrexate—systemic scleroderma	4.19e-05	0.000258	CcSEcCtD
Testosterone—Nausea—Mycophenolate mofetil—systemic scleroderma	4.11e-05	0.000253	CcSEcCtD
Testosterone—Chest pain—Methotrexate—systemic scleroderma	4.09e-05	0.000252	CcSEcCtD
Testosterone—Myalgia—Methotrexate—systemic scleroderma	4.09e-05	0.000252	CcSEcCtD
Testosterone—Arthralgia—Methotrexate—systemic scleroderma	4.09e-05	0.000252	CcSEcCtD
Testosterone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	4.06e-05	0.00025	CcSEcCtD
Testosterone—Fatigue—Prednisone—systemic scleroderma	4.05e-05	0.000249	CcSEcCtD
Testosterone—Discomfort—Methotrexate—systemic scleroderma	4.04e-05	0.000249	CcSEcCtD
Testosterone—Confusional state—Methotrexate—systemic scleroderma	3.95e-05	0.000243	CcSEcCtD
Testosterone—Anaphylactic shock—Methotrexate—systemic scleroderma	3.92e-05	0.000241	CcSEcCtD
Testosterone—Infection—Methotrexate—systemic scleroderma	3.9e-05	0.00024	CcSEcCtD
Testosterone—Feeling abnormal—Prednisone—systemic scleroderma	3.87e-05	0.000238	CcSEcCtD
Testosterone—Nervous system disorder—Methotrexate—systemic scleroderma	3.85e-05	0.000237	CcSEcCtD
Testosterone—Thrombocytopenia—Methotrexate—systemic scleroderma	3.84e-05	0.000236	CcSEcCtD
Testosterone—Gastrointestinal pain—Prednisone—systemic scleroderma	3.84e-05	0.000236	CcSEcCtD
Testosterone—Skin disorder—Methotrexate—systemic scleroderma	3.81e-05	0.000235	CcSEcCtD
Testosterone—Hyperhidrosis—Methotrexate—systemic scleroderma	3.79e-05	0.000233	CcSEcCtD
Testosterone—Urticaria—Prednisone—systemic scleroderma	3.73e-05	0.00023	CcSEcCtD
Testosterone—Abdominal pain—Prednisone—systemic scleroderma	3.71e-05	0.000228	CcSEcCtD
Testosterone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	3.57e-05	0.00022	CcSEcCtD
Testosterone—Insomnia—Methotrexate—systemic scleroderma	3.55e-05	0.000218	CcSEcCtD
Testosterone—Paraesthesia—Methotrexate—systemic scleroderma	3.52e-05	0.000217	CcSEcCtD
Testosterone—Dyspnoea—Methotrexate—systemic scleroderma	3.5e-05	0.000215	CcSEcCtD
Testosterone—Hypersensitivity—Prednisone—systemic scleroderma	3.46e-05	0.000213	CcSEcCtD
Testosterone—Gastrointestinal disorder—Methotrexate—systemic scleroderma	3.39e-05	0.000208	CcSEcCtD
Testosterone—Fatigue—Methotrexate—systemic scleroderma	3.38e-05	0.000208	CcSEcCtD
Testosterone—Asthenia—Prednisone—systemic scleroderma	3.37e-05	0.000207	CcSEcCtD
Testosterone—Pain—Methotrexate—systemic scleroderma	3.35e-05	0.000206	CcSEcCtD
Testosterone—Pruritus—Prednisone—systemic scleroderma	3.32e-05	0.000204	CcSEcCtD
Testosterone—Feeling abnormal—Methotrexate—systemic scleroderma	3.23e-05	0.000199	CcSEcCtD
Testosterone—Diarrhoea—Prednisone—systemic scleroderma	3.21e-05	0.000198	CcSEcCtD
Testosterone—Gastrointestinal pain—Methotrexate—systemic scleroderma	3.21e-05	0.000197	CcSEcCtD
Testosterone—Urticaria—Methotrexate—systemic scleroderma	3.12e-05	0.000192	CcSEcCtD
Testosterone—Dizziness—Prednisone—systemic scleroderma	3.1e-05	0.000191	CcSEcCtD
Testosterone—Abdominal pain—Methotrexate—systemic scleroderma	3.1e-05	0.000191	CcSEcCtD
Testosterone—Vomiting—Prednisone—systemic scleroderma	2.98e-05	0.000184	CcSEcCtD
Testosterone—Rash—Prednisone—systemic scleroderma	2.96e-05	0.000182	CcSEcCtD
Testosterone—Dermatitis—Prednisone—systemic scleroderma	2.96e-05	0.000182	CcSEcCtD
Testosterone—Headache—Prednisone—systemic scleroderma	2.94e-05	0.000181	CcSEcCtD
Testosterone—Hypersensitivity—Methotrexate—systemic scleroderma	2.89e-05	0.000178	CcSEcCtD
Testosterone—Asthenia—Methotrexate—systemic scleroderma	2.81e-05	0.000173	CcSEcCtD
Testosterone—Nausea—Prednisone—systemic scleroderma	2.79e-05	0.000172	CcSEcCtD
Testosterone—Pruritus—Methotrexate—systemic scleroderma	2.77e-05	0.000171	CcSEcCtD
Testosterone—Diarrhoea—Methotrexate—systemic scleroderma	2.68e-05	0.000165	CcSEcCtD
Testosterone—Dizziness—Methotrexate—systemic scleroderma	2.59e-05	0.00016	CcSEcCtD
Testosterone—Vomiting—Methotrexate—systemic scleroderma	2.49e-05	0.000154	CcSEcCtD
Testosterone—Rash—Methotrexate—systemic scleroderma	2.47e-05	0.000152	CcSEcCtD
Testosterone—Dermatitis—Methotrexate—systemic scleroderma	2.47e-05	0.000152	CcSEcCtD
Testosterone—Headache—Methotrexate—systemic scleroderma	2.46e-05	0.000151	CcSEcCtD
Testosterone—Nausea—Methotrexate—systemic scleroderma	2.33e-05	0.000143	CcSEcCtD
